ArticleJournal of gynecologic oncology2026
Cross-country inequalities and frontier analysis in global burden of cervical cancer: cross-sectional studies.
Article in Journal of gynecologic oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveThis research evaluated global health disparities of cervical cancer, and forecasted trends from 2022 to 2040.
methodsCross-country inequalities [Slope Index of Inequality (SII) and the Concentration Index] are used to measure inequality. Frontier analysis evaluates the medical quality by calculating the difference between actual values and frontier values. Average annual percentage changes (AAPCs) were computed to discern trends from 2022 to 2040.
resultsThe global SII for the age-standardized death rate (ASDR) of cervical cancer was -9.14 per 100,000 in 1990 and -9.62 in 2021. For age-standardized disability-adjusted life years (DALY) rate, the Concentration Index was -0.22 in 1990 and -0.30 in 2021. Frontier analysis calculated the difference between the actual value and the frontier value, indicating that countries with the most significant potential for reducing the disease burden of cervical cancer are Kiribati, Lesotho, Zimbabwe, Eswatini, and Eritrea. The global age standardized incidence rate (ASIR) and ASDR for cervical cancer are expected to decline by 2040, with an AAPC of -0.34 (95% confidence interval [CI]=-0.35 to -0.34) and -0.99 (95% CI=-0.99 to -0.99), respectively. However, in Eastern Europe, Central Latin America, Tropical Latin America, and Sub-Saharan Africa, the ASIR for cervical cancer is projected to continue rising through 2040. Unsafe sex is a contributing factor to cervical cancer deaths.
conclusionCross-national inequalities show that from 1990 to 2021, the trend of cervical cancer inequality has intensified and is concentrated in low socio-demographic index regions. Healthcare services in countries like Kiribati, Lesotho, and Zimbabwe need significant improvement.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.